QuidelOrtho authorizes $300M share repurchase over two years; cites confidence in cash generation

QuidelOrtho Corp

Board authorized repurchase of up to $300M of common stock through August 17, 2024.
Program reflects confidence in integration synergies, recurring revenue, and margin durability.
Company continues to prioritize R&D, manufacturing capacity, and debt paydown.
Repurchases are discretionary; may be made in open market or private transactions.
Program may be suspended, modified, or terminated at any time without notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.